Bill Gates: We Must Develop Drugs Much Faster in the Next Pandemicnews2022-04-15T20:51:28+00:00April 15th, 2022|The New York Times|
Psilocybin Helps Alleviate Depression Symptoms, Small Study Saysnews2022-04-11T19:54:55+00:00April 11th, 2022|The New York Times|
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Findsnews2022-03-30T22:45:15+00:00March 30th, 2022|The New York Times|
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Findsnews2022-03-30T21:12:29+00:00March 30th, 2022|The New York Times|
F.D.A. Rushed a Drug for Preterm Births. Did It Put Speed Over Science?news2022-03-25T15:15:07+00:00March 25th, 2022|The New York Times|
J. & J. Booster Protects Against Severe Omicron, Study Saysnews2021-12-30T10:45:18+00:00December 30th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
New Covid Antiviral Pills Offer Hope as Omicron Loomsnews2021-12-07T08:00:09+00:00December 7th, 2021|The New York Times|
The Variant Hunters: Inside South Africa’s Effort to Stanch Dangerous Mutationsnews2021-12-04T18:53:12+00:00December 4th, 2021|The New York Times|
